Ad is loading...
BCDA
Price
$1.85
Change
-$0.17 (-8.42%)
Updated
Nov 15 closing price
SMMT
Price
$18.31
Change
-$1.14 (-5.86%)
Updated
Nov 15 closing price
116 days until earnings call
Ad is loading...

BCDA vs SMMT

Header iconBCDA vs SMMT Comparison
Open Charts BCDA vs SMMTBanner chart's image
BioCardia
Price$1.85
Change-$0.17 (-8.42%)
Volume$77.41K
CapitalizationN/A
Summit Therapeutics
Price$18.31
Change-$1.14 (-5.86%)
Volume$2.15M
CapitalizationN/A
BCDA vs SMMT Comparison Chart
Loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BCDA vs. SMMT commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCDA is a StrongSell and SMMT is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (BCDA: $1.85 vs. SMMT: $18.31)
Brand notoriety: BCDA and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCDA: 65% vs. SMMT: 43%
Market capitalization -- BCDA: $6.48M vs. SMMT: $13.5B
BCDA [@Biotechnology] is valued at $6.48M. SMMT’s [@Biotechnology] market capitalization is $13.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCDA’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 2 green FA rating(s).

  • BCDA’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 2 green, 3 red.
According to our system of comparison, SMMT is a better buy in the long-term than BCDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCDA’s TA Score shows that 4 TA indicator(s) are bullish while SMMT’s TA Score has 2 bullish TA indicator(s).

  • BCDA’s TA Score: 4 bullish, 5 bearish.
  • SMMT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BCDA is a better buy in the short-term than SMMT.

Price Growth

BCDA (@Biotechnology) experienced а -18.14% price change this week, while SMMT (@Biotechnology) price change was -14.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

BCDA is expected to report earnings on Aug 13, 2024.

SMMT is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($13.5B) has a higher market cap than BCDA($6.48M). SMMT YTD gains are higher at: 601.533 vs. BCDA (-81.431). BCDA has higher annual earnings (EBITDA): -8.53M vs. SMMT (-183.16M). SMMT has more cash in the bank: 487M vs. BCDA (1.42M). BCDA has less debt than SMMT: BCDA (1.14M) vs SMMT (32.5M). BCDA has higher revenues than SMMT: BCDA (428K) vs SMMT (0).
BCDASMMTBCDA / SMMT
Capitalization6.48M13.5B0%
EBITDA-8.53M-183.16M5%
Gain YTD-81.431601.533-14%
P/E RatioN/A26.36-
Revenue428K0-
Total Cash1.42M487M0%
Total Debt1.14M32.5M4%
FUNDAMENTALS RATINGS
BCDA vs SMMT: Fundamental Ratings
BCDA
SMMT
OUTLOOK RATING
1..100
6310
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
10026
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9634
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
6585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCDA's Valuation (55) in the null industry is somewhat better than the same rating for SMMT (94) in the Biotechnology industry. This means that BCDA’s stock grew somewhat faster than SMMT’s over the last 12 months.

SMMT's Profit vs Risk Rating (26) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

SMMT's SMR Rating (97) in the Biotechnology industry is in the same range as BCDA (100) in the null industry. This means that SMMT’s stock grew similarly to BCDA’s over the last 12 months.

SMMT's Price Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for BCDA (96) in the null industry. This means that SMMT’s stock grew somewhat faster than BCDA’s over the last 12 months.

SMMT's P/E Growth Rating (11) in the Biotechnology industry is significantly better than the same rating for BCDA (100) in the null industry. This means that SMMT’s stock grew significantly faster than BCDA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCDASMMT
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
77%
Bullish Trend 7 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
View a ticker or compare two or three
Ad is loading...
BCDA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNT60.981.48
+2.49%
Alliant Energy Corp
PRA16.880.07
+0.42%
ProAssurance Corp
PSMT87.21-0.89
-1.01%
PriceSmart
ZOM0.14N/A
-2.17%
Zomedica Corp
VIRX0.15-0.01
-4.37%
Viracta Therapeutics

BCDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCDA has been closely correlated with SMMT. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BCDA jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCDA
1D Price
Change %
BCDA100%
-8.19%
SMMT - BCDA
68%
Closely correlated
-5.86%
MDGL - BCDA
29%
Poorly correlated
-4.66%
PDSB - BCDA
29%
Poorly correlated
-10.67%
INO - BCDA
28%
Poorly correlated
-10.59%
KOD - BCDA
28%
Poorly correlated
+4.34%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-5.86%
BCDA - SMMT
70%
Closely correlated
-8.19%
VBIZF - SMMT
42%
Loosely correlated
N/A
DAWN - SMMT
32%
Poorly correlated
-7.05%
ERNA - SMMT
31%
Poorly correlated
-12.04%
BNTX - SMMT
31%
Poorly correlated
-3.71%
More